Every year 186,000 men in the United States are diagnosed with prostate cancer and nearly 30,000 die of it. With early detection and treatment, many of those lives can be saved. That's why in 2000, Thor Industries launched the first-ever mobile prostate cancer-screening vehicle in a program called the Drive Against Prostate Cancer (the Drive). Since its introduction, the Drive has provided free prostate cancer screenings to more than 87,000 men on board its two custom designed Airstream mobile medical clinics. The Drive has been to the U. S. Senate, the New York Stock Exchange, Times Square, major league ballparks, NASCAR races, state fairs, and large and small cities and towns all around the country.

About 12% of men screened on the Drive have an elevated PSA. Because of the early detection made possible by the Drive, thousands of lives have likely been saved.

Wade F. B. Thompson, Thor's Chairman, President, and CEO, and a prostate cancer survivor, was the principal impetus in the founding of the Drive Against Prostate Cancer. "This program has been enormously successful in early detection of the disease by providing a screening resource to thousands of men who may not otherwise have sought or received prostate cancer screening. We have raised the awareness of this silent killer and have probably saved thousands of lives as a result," said Mr. Thompson. "As the world's leading manufacturer of RVs and buses, Thor is in a unique position to provide a life-saving service in the form of these mobile screening facilities," he added.

In partnership with ZERO - The Project to End Prostate Cancer, which manages the program and schedules the events, the Drive provides quality medical care at each screening event. Each man receives a blood test for Prostate Specific Antigen (PSA) and a physical exam, the Digital Rectal Exam (DRE). A licensed phlebotomist draws the blood samples and an urologist, urology resident, or general practitioner performs the physical exam. Test results are e-mailed to a cancer center for evaluation, and each man receives a notification letter briefly explaining the test results and providing links to information on the web, a toll-free phone number to ZERO, and a contact at the cancer center. Men with abnormal results receive a second letter urging them to seek medical advice immediately.

No one is screened without a "medical home." ZERO contacts area hospitals and city, county, or state health agencies to ensure health services for those who may need follow-up medical care but cannot afford it.

If you would like to learn more about the Drive Against Prostate Cancer (ZeroCancer.org/Drive) upcoming events, or how you can become a partner in this life-saving effort, contact ZERO-The Project to End Prostate Cancer, 10 G St. NE, Suite 601, Washington, DC 20002; or call 202-463-9455.